AKUMS DRUGS AND PHARMA L Share Price

₹ 733.15

+₹1.45 (0.20%)
1D
Last updated 02 Nov, 2026, 15:52 IST
NSE: AKUMS
|
Pharmaceuticals

AKUMS DRUGS AND PHARMA L Share Price Today

As of 3 Nov 2026, AKUMS DRUGS AND PHARMA L share price is ₹733.15. The stock opened at ₹734.00, compared to its previous close of ₹731.70. During today's trading session, AKUMS DRUGS AND PHARMA L share price moved in the range of ₹725.20 to ₹740.90, with an average price of ₹733.05 for the day. Looking at its last 52-week, the stock has touched a low of ₹409.30 and a high of ₹838.80. On the performance front, AKUMS DRUGS AND PHARMA L share price has increased by 33.96% over the last six months and is up 59.12% on a year-on-year basis.

Share price over the last 1 day rose from 732.70 to 736.00, ranging between 725.75 and 737.10.
₹725.20
0.20% up today
₹740.90
1D LOW
1D HIGH

AKUMS DRUGS AND PHARMA L Stock Insights

Latest Earning
Op Profit TrendUp by 14.87% QoQ
Latest Earning
Net Profit TrendUp by 24.15% QoQ
Latest Earning
Revenue TrendUp by 0.32% QoQ
Stock Performance
OutperformingBeat Nifty by 16.6 % in last 3 month
Shareholding Pattern
DIIDII decreased stake by 4.49%
Shareholding Pattern
FIIFII increased stake by 135.71%
Technical Indicators
MACD CrossThe MACD line crossed above the signal line on 1 Day interval.
AKUMS DRUGS AND PHARMA L stock performance
Open₹734.00
High₹740.90
Low₹725.20
Prev. close₹731.70
AKUMS DRUGS AND PHARMA L trading activity
Volume99,789
Average traded price₹730.99
Last traded time03:52:22 02 Nov
Last traded quantity22
Circuit
L
H
₹659.85
₹806.45
52-week
L
H
₹409.30
₹838.80
Mkt Cap Cr
11,519.67
P/E
39.35
P/B
3.48
ROA
5.37%
ROE
7.7%
ROCE
10.95%
Quick Ratio
2.56
EV/EBITDA
14.69

Based on fundamentals, this stock's

Performance: 1 out of 5, Very Poor
Performance
Very Poor
Akums Drugs has not beaten FD return of 7%
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Akums Drugs appears overvalued compared to its peers
Earnings: 5 out of 5, Excellent
Earnings
Excellent
Akums Drugs revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,26,661.7438.834.789.61%13.79%18.65%2.3122.27
Divis Laboratories2,57,902.7388.1715.3914.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,74,402.4783.099.494.7%11.42%11.37%0.7533.6
Laurus Labs1,26,811.2895.1720.9211.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,24,089.4827.024.588.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,12,698.5340.842.94.79%7.21%8.58%1.3519.05
Cipla1,11,486.1439.063.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,796.6045.425.857.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,536.9026.022.556.34%9.25%11.76%1.1512.38
Lupin91,870.1616.554.0914.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

AKUMS DRUGS AND PHARMA L Company Background

ISIN
INE09XN01023
Sector Market Cap
₹ 11,519.67 Cr

Akums Drugs and Pharmaceuticals Limited is an India-based pharmaceutical contract development and manufacturing company. The Company offers a comprehensive range of pharmaceutical products and services in India and overseas. The Company’s segments include Contract Development and Manufacturing Operations (CDMO), Active Pharmaceutical Ingredient (API), Domestic Branded Formulations, International Branded Formulations, and Trade Generics. The CDMO segment is engaged in formulation research and development, preparation and regulatory filing of dossiers, manufacturing formulations on a contract basis, job work and testing services. The API segment is engaged in the manufacture and sale of key starting materials, Intermediate and API products. The Domestic Branded Formulations segment includes marketing of its branded formulations in the Indian market. The International Branded Formulations segment undertakes the marketing of its branded formulations in the global market.

AKUMS DRUGS AND PHARMA L Financial Highlights

  • Revenue: AKUMS DRUGS AND PHARMA L reported revenue of ₹4,487.75 crore in FY26 vs ₹4,170.28 crore in FY25. It showed an increase of 7.61% on a yearly basis.
  • Operating Profit: AKUMS DRUGS AND PHARMA L reported an operating profit of ₹382.10 crore in FY26 vs ₹345.25 crore in FY25. It showed an increase of 10.67% on a year-on-year basis.
  • Net Profit: AKUMS DRUGS AND PHARMA L reported a net profit of ₹256.40 crore in FY26 vs ₹343.78 crore in FY25. It showed a decrease of 25.42% on a yearly basis.

AKUMS DRUGS AND PHARMA L Quarterly Result Highlights

  • AKUMS DRUGS AND PHARMA L reported revenue of ₹1,197.01 crore in Jun 2026, compared with ₹1,193.17 crore in Mar 2026, representing an increase of 0.32% on a quarter-on-quarter (QoQ) basis.
  • AKUMS DRUGS AND PHARMA L reported an operating profit of ₹139.24 crore in Jun 2026, compared with ₹121.22 crore in Mar 2026, representing an increase of 14.87% on a quarter-on-quarter (QoQ) basis.
  • AKUMS DRUGS AND PHARMA L reported a profit of ₹100.98 crore in Jun 2026, compared with ₹81.34 crore in Mar 2026, reflecting an increase of 24.15% on a QoQ basis.
  • The earnings per share (EPS) of AKUMS DRUGS AND PHARMA L stood at ₹16.67 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
75.26%
FII
4.50%
Other DII
3.51%
Retail and other
9.16%
Mutual funds
7.58%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20251.15%
Mar 20261.37%
Jun 20261.91%
Sep 20264.50%

AKUMS DRUGS AND PHARMA L Investment Returns

1 day
+0.20%
1 week
+6.78%
1 month
-9.83%
1 year
+59.12%
3 years
-7.92%
5 years
-7.92%

AKUMS DRUGS AND PHARMA L Share Price History

AKUMS DRUGS AND PHARMA L share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
02 Nov 26
₹734.00 / ₹733.15
+0.20%
30 Oct 26
₹750.00 / ₹731.70
-1.26%
29 Oct 26
₹717.60 / ₹741.05
+2.54%
28 Oct 26
₹715.00 / ₹722.70
+0.48%
Show more

AKUMS DRUGS AND PHARMA L Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹4,359.02₹4,118.16₹4,178.18₹3,654.82
Other Income₹128.73₹52.12₹34.03₹90.07
Total Revenue₹4,487.74₹4,170.28₹4,212.21₹3,744.89
Total Expenses₹4,085.62₹3,841.72₹4,231.45₹3,519.89
Profit Before Tax₹382.10₹345.25-₹45.28₹150.30
Tax₹125.70₹1.48-₹46.07₹52.48
Profit After Tax₹256.40₹343.78₹0.79₹97.82
EPS - Basic₹16.67₹22.60-₹0.28₹6.63
EPS - Diluted₹16.67₹22.60-₹0.28₹6.63

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹382.10₹345.25-₹45.28₹150.30
Income before WC changes₹546.36₹512.96₹510.81₹308.03
Change in Assets-₹205.31-₹65.77₹47.13₹9.25
Change in Liabilities₹927.52₹99.24₹2.74-₹43.58
Change in WC₹722.21₹33.47₹49.87-₹34.33
Cash flow from Operations₹1,181.20₹465.20₹498.26₹176.63
Cash flow from Investing-₹930.27-₹547.84-₹330.42-₹304.70
Cash flow from Financing₹33.88₹72.79-₹108.02₹124.54
Total Cash Flow₹284.81-₹9.86₹59.82-₹3.53
Cash (Start of the year)₹101.19₹111.05₹51.61₹55.14
Cash (End of the year)₹386.01₹101.19₹111.05₹51.61

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹1,887.11₹1,838.83₹1,575.48₹1,387.66
Current Assets₹3,559.86₹2,274.61₹1,940.88₹1,878.87
Total Assets₹5,446.97₹4,113.44₹3,516.37₹3,266.53
Current Liabilities₹1,094.76₹893.75₹1,210.55₹1,265.57
Net Current Asset₹2,465.10₹1,380.86₹730.33₹613.31
Non-Current Liabilities₹1,021.09₹156.08₹1,585.33₹1,277.59
Equity Capital₹3,331.12₹3,063.61₹720.49₹723.37
Total Equity & Liabilities₹5,446.97₹4,113.44₹3,516.37₹3,266.53

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹1,348.74₹1,311.78₹1,444.12₹1,286.83
Other Income₹112.97₹124.19₹94.12₹96.15
Total Revenue₹1,461.70₹1,435.98₹1,538.24₹1,382.98
Total Expenses₹1,306.82₹1,228.14₹1,621.78₹1,088.13
Profit Before Tax₹148.37₹207.84-₹102.93₹150.32
Tax₹36.73₹46.84₹62.52₹24.89
Profit After Tax₹111.64₹161.00-₹165.45₹125.43
EPS - Basic₹7.29₹10.76-₹11.56₹8.77
EPS - Diluted₹7.29₹10.76-₹11.56₹8.77

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹148.37₹207.84-₹102.93₹150.32
Income before WC changes₹111.21₹150.83₹241.07₹118.58
Change in Assets-₹86.41-₹24.94₹42.78₹23.14
Change in Liabilities₹8.90₹13.97₹0.35-₹106.13
Change in WC-₹77.51-₹10.96₹43.12-₹83.00
Cash flow from Operations-₹2.15₹91.00₹247.91₹94.01
Cash flow from Investing-₹24.97-₹458.84-₹165.44-₹202.17
Cash flow from Financing-₹3.00₹375.38-₹20.74₹89.90
Total Cash Flow-₹30.11₹7.54₹61.72-₹18.26
Cash (Start of the year)₹76.49₹68.96₹7.23₹25.49
Cash (End of the year)₹46.38₹76.49₹68.96₹7.23

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹1,488.98₹1,851.73₹1,562.18₹1,373.13
Current Assets₹1,323.50₹833.18₹533.24₹521.08
Total Assets₹2,812.48₹2,684.91₹2,095.43₹1,894.21
Current Liabilities₹304.00₹309.31₹501.74₹496.56
Net Current Asset₹1,019.50₹523.87₹31.50₹24.53
Non-Current Liabilities₹80.92₹70.36₹1,449.81₹1,086.15
Equity Capital₹2,427.57₹2,305.25₹143.88₹311.50
Total Equity & Liabilities₹2,812.48₹2,684.91₹2,095.43₹1,894.21
* All values are in INR Crore
AKUMS DRUGS AND PHARMA L market depth
Bid quantityBid priceAsk priceAsk quantity
578733.1500
0000
0000
0000
0000
Total bid quantity578
Total ask quantity0
AKUMS DRUGS AND PHARMA L technical summary
Bearish indicators3
Neutral indicators5
Bullish indicators0
OverallSlightly Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
46.97
Neutral
ATR (14)
29.34
Neutral
STOCH(9,6)
75.98
Neutral
STOCH RSI (14)
89.77
Bearish
ADX(9)
37.54
Bearish
UO(9)
57.98
Neutral
ROC(12)
-4.89
Bearish
WillR(14)
-37.54
Neutral
Period
Simple value
Exponential vaue
5D
720.26
723.54
10D
708.55
723.57
20D
745.81
737.41
50D
764.68
742.32
100D
712.71
706.48
Volume trend — traded volume by day
2 Nov0L
30 Oct1L
29 Oct1L
28 Oct0L
27 Oct1L
Average1L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

AKUMS DRUGS AND PHARMA L
Pharmaceuticals
Add Stock
Add Another

Mutual Funds Invested in AKUMS DRUGS AND PHARMA L

Fund name
AUM
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
1.77%
Franklin India Opportunities Fund
1.47%
Templeton India Value Fund
1.30%

AKUMS DRUGS AND PHARMA L Returns Calculator

Ex-date: 03 Jul 2026
Ex-date: 03 Jul 2026

AKUMS DRUGS AND PHARMA L Latest News

4 months ago
Stock market rally: Aegis Logistics, Cupid, Akums Drugs, JB Chemicals, among 47 stocks that hit 52-week high on NSE
Showing news item 1 of 1

Top Gainers

ITI Share Price
₹259.14
+43.19 (+20%)
ENGINERSIN Share Price
₹289.65
+37.8 (+15.01%)
AFFLE Share Price
₹1506.50
+164.7 (+12.27%)
PRAJIND Share Price
₹271.13
+29.43 (+12.18%)
DIXON Share Price
₹12319.00
+1319 (+11.99%)
See more

Top Losers

INDIGOPNTS Share Price
₹870.00
-127.3 (-12.76%)
CLEAN Share Price
₹662.60
-53 (-7.41%)
ZEEL Share Price
₹61.58
-4.82 (-7.26%)
SYRMA Share Price
₹1512.00
-113.3 (-6.97%)
POLICYBZR Share Price
₹931.00
-69.1 (-6.91%)
See more

AKUMS DRUGS AND PHARMA L Share Price FAQs

Please be aware that AKUMS DRUGS AND PHARMA L stock prices are subject to continuous fluctuations due to various factors.